Literature DB >> 25605767

Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumannii.

Steven E Fiester1, Chika C Nwugo1, William F Penwell1, John M Neary1, Amber C Beckett1, Brock A Arivett1, Robert E Schmidt1, Sarah C Geiger1, Pamela L Connerly1, Sharon M Menke1, Andrew P Tomaras1, Luis A Actis2.   

Abstract

Acinetobacter baumannii is a Gram-negative opportunistic nosocomial pathogen that causes pneumonia and soft tissue and systemic infections. Screening of a transposon insertion library of A. baumannii ATCC 19606T resulted in the identification of the 2010 derivative, which, although capable of growing well in iron-rich media, failed to prosper under iron chelation. Genetic, molecular, and functional assays showed that 2010's iron utilization-deficient phenotype is due to an insertion within the 3' end of secA, which results in the production of a C-terminally truncated derivative of SecA. SecA plays a critical role in protein translocation through the SecYEG membrane channel. Accordingly, the secA mutation resulted in undetectable amounts of the ferric acinetobactin outer membrane receptor protein BauA while not affecting the production of other acinetobactin membrane protein transport components, such as BauB and BauE, or the secretion of acinetobactin by 2010 cells cultured in the presence of subinhibitory concentrations of the synthetic iron chelator 2,2'-dipyridyl. Outer membrane proteins involved in nutrient transport, adherence, and biofilm formation were also reduced in 2010. The SecA truncation also increased production of 30 different proteins, including proteins involved in adaptation/tolerance responses. Although some of these protein changes could negatively affect the pathobiology of the 2010 derivative, its virulence defect is mainly due to its inability to acquire iron via the acinetobactin-mediated system. These results together indicate that although the C terminus of the A. baumannii ATCC 19606T SecA is not essential for viability, it plays a critical role in the production and translocation of different proteins and virulence.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25605767      PMCID: PMC4363421          DOI: 10.1128/IAI.02925-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

Review 1.  The Sec translocase.

Authors:  David J F du Plessis; Nico Nouwen; Arnold J M Driessen
Journal:  Biochim Biophys Acta       Date:  2010-08-27

2.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

Review 3.  Acinetobacter in modern warfare.

Authors:  M K O'Shea
Journal:  Int J Antimicrob Agents       Date:  2012-03-28       Impact factor: 5.283

4.  The Salmonella enterica serovar Typhimurium QseB response regulator negatively regulates bacterial motility and swine colonization in the absence of the QseC sensor kinase.

Authors:  Bradley L Bearson; Shawn M D Bearson; In Soo Lee; Brian W Brunelle
Journal:  Microb Pathog       Date:  2010-03-19       Impact factor: 3.738

5.  Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice.

Authors:  Jennifer A Gaddy; Brock A Arivett; Michael J McConnell; Rafael López-Rojas; Jerónimo Pachón; Luis A Actis
Journal:  Infect Immun       Date:  2012-01-09       Impact factor: 3.441

6.  Functional characterization of ExFadLO, an outer membrane protein required for exporting oxygenated long-chain fatty acids in Pseudomonas aeruginosa.

Authors:  Eriel Martínez; Mónica Estupiñán; F I Javier Pastor; Montserrat Busquets; Pilar Díaz; Angeles Manresa
Journal:  Biochimie       Date:  2012-10-12       Impact factor: 4.079

7.  The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells.

Authors:  Jennifer A Gaddy; Andrew P Tomaras; Luis A Actis
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

Review 8.  SecA, a remarkable nanomachine.

Authors:  Ilja Kusters; Arnold J M Driessen
Journal:  Cell Mol Life Sci       Date:  2011-04-10       Impact factor: 9.261

9.  Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii.

Authors:  Chika C Nwugo; Brock A Arivett; Daniel L Zimbler; Jennifer A Gaddy; Ashley M Richards; Luis A Actis
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  The Acinetobacter baumannii entA gene located outside the acinetobactin cluster is critical for siderophore production, iron acquisition and virulence.

Authors:  William F Penwell; Brock A Arivett; Luis A Actis
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

View more
  8 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Inhibition of AAC(6')-Ib-mediated resistance to amikacin in Acinetobacter baumannii by an antisense peptide-conjugated 2',4'-bridged nucleic acid-NC-DNA hybrid oligomer.

Authors:  Christina Lopez; Brock A Arivett; Luis A Actis; Marcelo E Tolmasky
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  The StkSR Two-Component System Influences Colistin Resistance in Acinetobacter baumannii.

Authors:  Sarah K Giles; Uwe H Stroeher; Bhavya Papudeshi; Robert A Edwards; Jessica Ap Carlson-Jones; Michael Roach; Melissa H Brown
Journal:  Microorganisms       Date:  2022-05-08

4.  Synthetic Porcine Hepcidin Exhibits Different Roles in Escherichia coli and Salmonella Infections.

Authors:  Dan Liu; Zhen-Shun Gan; Wan Ma; Hai-Tao Xiong; Yun-Qing Li; Yi-Zhen Wang; Hua-Hua Du
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

5.  Critical role of bacterial isochorismatase in the autophagic process induced by Acinetobacter baumannii in mammalian cells.

Authors:  Yang Wang; Kaiyu Zhang; Xiaochen Shi; Chao Wang; Feng Wang; Junwen Fan; Fengge Shen; Jiancheng Xu; Wanguo Bao; Mingyuan Liu; Lu Yu
Journal:  FASEB J       Date:  2016-07-18       Impact factor: 5.191

6.  Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii.

Authors:  Steven E Fiester; Brock A Arivett; Robert E Schmidt; Amber C Beckett; Tomislav Ticak; Mary V Carrier; Rajarshi Ghosh; Emily J Ohneck; Maeva L Metz; Marlo K Sellin Jeffries; Luis A Actis
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

7.  Effect of Hcp Iron Ion Regulation on the Interaction Between Acinetobacter baumannii With Human Pulmonary Alveolar Epithelial Cells and Biofilm Formation.

Authors:  Ping Pan; Xiaolei Wang; Yi Chen; Qiong Chen; Yunxing Yang; Chenxing Wei; Tongtong Cheng; Haitong Wan; Daojun Yu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 5.293

8.  An Unprecedented Tolerance to Deletion of the Periplasmic Chaperones SurA, Skp, and DegP in the Nosocomial Pathogen Acinetobacter baumannii.

Authors:  Karolin Birkle; Fabian Renschler; Angel Angelov; Gottfried Wilharm; Mirita Franz-Wachtel; Boris Maček; Erwin Bohn; Elena Weber; Jennifer Müller; Lea Friedrich; Monika Schütz
Journal:  J Bacteriol       Date:  2022-09-15       Impact factor: 3.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.